Fresenius Medical Care AG

BMV:FME N Stock Report

Market Cap: Mex$231.3b

Fresenius Medical Care KGaA Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Helen Giza

Chief executive officer

€3.2m

Total compensation

CEO salary percentage43.1%
CEO tenure3.6yrs
CEO ownershipn/a
Management average tenure3.5yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Helen Giza's remuneration changed compared to Fresenius Medical Care KGaA's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

€602m

Dec 31 2022€3m€1m

€673m

Sep 30 2022n/an/a

€763m

Jun 30 2022n/an/a

€806m

Mar 31 2022n/an/a

€878m

Dec 31 2021€2m€855k

€969m

Sep 30 2021n/an/a

€918m

Jun 30 2021n/an/a

€998m

Mar 31 2021n/an/a

€1b

Dec 31 2020€2m€855k

€1b

Sep 30 2020n/an/a

€1b

Jun 30 2020n/an/a

€1b

Mar 31 2020n/an/a

€1b

Dec 31 2019€2m€108k

€1b

Compensation vs Market: Helen's total compensation ($USD3.46M) is below average for companies of similar size in the MX market ($USD5.70M).

Compensation vs Earnings: Helen's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Helen Giza (55 yo)

3.6yrs

Tenure

€3,214,000

Compensation

Ms. Helen Giza is Chief Executive Officer of the Management Board of Fresenius Medical Care AG & Co. KGaA from December 6, 2022. She serves as a Member of the Management Board - Fresenius Management SE at...

Leadership Team

NamePositionTenureCompensationOwnership
Helen Giza
CEO, Acting CFO & Chair of Mgmt Board of Fresenius Med. Care Mgmt AG3.6yrs€3.21mno data
Franklin Maddux
Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG3.4yrs€2.64mno data
William Valle
Management Board Member for Care Delivery of Fresenius Medical Care Management AG6.3yrs€4.93mno data
Katarzyna Mazur-Hofsab
Management Board Member for Care Enablement of Fresenius Medical Care Management AG1.4yrs€2.71mno data
Roberto Fuste
Executive Advisor for Regional Strategyno datano datano data
Nwamaka Eneanya
Head of Strategy & Operations1.2yrsno datano data
Dominik Heger
Executive VP and Head of Investor Relationsno datano datano data
Borries Muller
Senior Vice President of Global Human Resources Employee Communicationsno datano datano data
Joachim Weith
Senior Vice President of Corporate Communications & Governmental Affairsno datano datano data
Oliver Maier
Senior Vice President Investor Relationsno datano datano data
Gail-Suzanne Brown
Senior Vice President of Research & Developmentno datano datano data
Glenn Slater
Senior Vice President of Manufacturing and Supply Chain Operationsno datano datano data

3.5yrs

Average Tenure

62.5yo

Average Age

Experienced Management: FME N's management team is considered experienced (3.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Rolf Classon
Independent Vice Chairman of Supervisory Board12.1yrs€399.00kno data
Dieter Schenk
Chairman of Supervisory Board5.1yrs€437.00kno data
Gregor Zund
Independent Member of Supervisory Board4.7yrs€152.00kno data
Michael Sen
Chairman of the Supervisory Board of Fresenius Medical Care Management AGless than a year€114.00kno data
Pascale Witz
Independent Member of Supervisory Board7.1yrs€209.00kno data
Ilse Wenzel
Lead Independent Member of Supervisory Board4.1yrs€228.00kno data
Gregory Sorensen
Independent Member of Supervisory2.1yrs€152.00kno data
Sara Hennicken
Member of Supervisory Board at Fresenius Medical Care Management AGno data€50.00kno data

4.7yrs

Average Tenure

58.5yo

Average Age

Experienced Board: FME N's board of directors are considered experienced (4.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/12 14:07
End of Day Share Price 2023/03/16 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fresenius Medical Care AG is covered by 59 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Brian WilliamsAvondale Partners
Olav ZilianBaader Helvea Equity Research